Statin-induced delayed rhabdomyolysis

BMJ Case Rep. 2019 Sep 6;12(9):e231125. doi: 10.1136/bcr-2019-231125.

Abstract

An elderly woman with a history of hypertension, hypothyroidism, mesenteric vein thrombosis, depression and hyperlipidaemia on statins for >9 years presented with new-onset leg weakness, falls, dark-coloured urine, transaminitis and rhabdomyolysis (creatinine phosphokinase 12 896 U/L; aldolase 45.9 (normal <7.7 U/L). Workup for autoimmune myositis was negative. The patient had clinical and laboratory improvement with discontinuation of statins with the return of clinical strength and creatinine phosphokinase back to baseline levels (51 U/L) within 2 weeks.

Keywords: Drug Interactions; Musculoskeletal And Joint Disorders; Pain.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Creatine Kinase / drug effects*
  • Female
  • Fluid Therapy
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects*
  • Rhabdomyolysis / blood
  • Rhabdomyolysis / chemically induced*
  • Rhabdomyolysis / physiopathology
  • Rhabdomyolysis / therapy
  • Treatment Outcome

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Creatine Kinase